Plain-English translation of NCT07686380 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Sponsor
National Cancer Institute (NCI)
Enrollment target
~65 participants
Started
August 2026
Primary completion
January 2029
Age range
18 Years – 120 Years
Sex
Male only
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amy R Hankin, P.A.-C
National Cancer Institute (NCI)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.